Prostate Cancer

Drug Pipeline Update 2007

Publication Date	May 2007
Publisher	Bioseeker
Product Type	CD-ROM
Pages
ISBN Number	not applicable
Product Code	BSK00053

Price

£1,370.00
approximately: $2,002 | €1,501

CD-ROM £1,370 ($2,002 | €1,501)

Order above formats by FAX

Summary

Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players` sales have been eroded by the launch of various LHRH agonist depot formulations. Safety concerns with AstraZeneca`s Casodex (bicalutamide) have also seen a significant proportion of physicians switching to alternatives. Establishing the optimal timing of antihormonal therapy will provide the key to market growth..

There are today no less than 280 therapeutics targeting prostate cancer, from early preclinical to marketed drugs. Prostate Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to more than 140 different targets. These targets are further categorized on the CD-ROM by 46 classifications of molecular function and their possible belonging to 20 different signaling pathways in the cell. Read more below on how the Prostate Cancer Drug Pipeline Update is organized.

How May Drug Pipeline Update Be of Use?

Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
Find competitors, collaborations partners, M&A candidates etc.
Jump start competitive drug intelligence operations
Excellent starting point for world wide benchmarking
Compare portfolio and therapy focus with your peers
Speed up pro-active in-/out licensing strategy work
Fast and easy way of tracking drugs using search engines; just one click and you may search the World Wide Web and PubMed for any drug.
Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below.

Drug Pipeline Update at a Glance

Investigators Includes more than 200 principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators.
Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator.

Drug name & Synonyms Lists commercial, generic and code names for drugs. In all more than 400 names
Developmental stage This Drug Pipeline Update contains more than 280 drugs in active development for the treatment of prostate cancer:

23 marketed drugs

10 drugs in Phase III
115 drugs in Phase II
55 drugs in Phase I
70 drugs in Preclinical

Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application.

Indications Included prostate cancer drugs are also in development for over 120 other indications
Note: You are able to sort and find drugs according to type of indication from drop-down menu in the application.

Targets Identified drugs are linked to more than 140 different targets, divided into 46 classifications of molecular function:

Carboxy-lyase activity
Carboxypeptidase activity
Catalytic activity
Cell adhesion molecule activity
Chemokine activity
Complement activity
Cysteine-type peptidase activity
Cytokine activity
DNA topoisomerase activity
DNA-directed DNA polymerase activity
G-protein coupled receptor activity
Growth factor activity
Hormone activity
Hydrolase activity
Isomerase activity
Kinase activity
Ligand-dependent nuclear receptor activity
Ligase activity
Lipid kinase activity
Lipid phosphatase activity
Metallopeptidase activity
MHC class I receptor activity
Molecular function unknown
Motor activity
Oxidoreductase activity
Peptide hormone
Peroxidase activity
Phosphoric diester hydrolase activity
Protein binding
Protein serine/threonine kinase activity
Protein-tyrosine kinase activity
Receptor activity
Receptor binding
Receptor signaling complex scaffold activity
Receptor signaling protein serine/threonine kinase activity
RNA binding
RNA-directed DNA polymerase activity
Serine-type peptidase activity
Structural constituent of cytoskeleton
T cell receptor activity
Transcription factor activity
Transcription regulator activity
Translation regulator activity
Transmembrane receptor activity
Transmembrane receptor protein tyrosine kinase activity
Transporter activity

Identified targets are categorized into 20 different primary and alternate localizations:

Centrosome
Clathrin-coated vesicle
Cytoplasm
Cytoskeleton
Cytosol
Endoplasmic reticulum
Endosome
Extracellular
Extracellular matrix
Golgi apparatus
Integral to membrane
Lysosome
Mitochondrial membrane
Mitochondrion
Nucleolus
Nucleus
Perinuclear region
Plasma membrane
Secretory granule
Nuclear membrane

Note: You are able to sort and find drugs according to target name, molecular function of target, and target localization from drop-down menus in the application.

Target Expression Profile Direct links are provided from inside the application to protein expression profiles of 57 drug targets in various human tissues, cell lines and primary cells, including up to:

48 different normal tissue types
20 different types of cancer
47 cell lines
12 samples of primary blood cells

Targeted Signaling Pathways Identified targets have been cross referenced against 20 signaling pathways, and all signaling pathways are currently being targeted in prostate cancer drug development:

Alpha6 Beta4 Integrin Signaling Pathway
Androgen Receptor Signaling Pathway
B Cell Receptor Signaling Pathway
EGFR1 Signaling Pathway
Hedgehog Signaling Pathway
ID Signaling Pathway
IL-1 Signaling Pathway
IL-2 Signaling Pathway
IL-3 Signaling Pathway
IL-4 Signaling Pathway
IL-5 Signaling Pathway
IL-6 Signaling Pathway
IL-7 Signaling Pathway
IL-9 Signaling Pathway
Kit Receptor Signaling Pathway
Notch Signaling Pathway
T Cell Receptor Signaling Pathway
TGF-beta Receptor Signaling Pathway
TNF-alpha Signaling Pathway
Wnt Signaling Pathway

Note: You are able to sort and find drugs according to targeted signaling pathway from drop-down menu in the application.

Mechanism In total there are at least 160 different drug mechanism of action represented in this Drug Pipeline Update.
Note: You are able to sort and find drugs according to mechanism of action from drop-down menu in the application.

Compound Identified drug compounds are described by:
Compound type, Chemical name, CAS Number and molecular weight

Note: You are able to sort and find drugs according to compound type from drop-down menu in the application.

Drug Profile Progress analysis and review of drug development. A typical drug profile reports on, depending on stage of development and available information:
Drug Name & Synonyms
Presentation of drug name and synonyms (if any)

Principal Investigator & Partners
Presentation of principal investigator and partners (if any)

Target and Molecular Function of Target
Described target(s) is/are presented with:
Official Gene Symbol - Official Gene Name [Species/Homo Sapiens] - Molecular Function

Target Localization
Described target(s) is/are presented with primary and alternate localizations.

Target Expression Profiles
Links to protein expression profile(s) of target(s) in various human tissues, cell lines and primary cells, including up to:
48 different normal tissue types
20 different types of cancer
47 cell lines
12 samples of primary blood cells

Targeted Signaling Pathways
Described target(s) is/are matched for the involvement in 20 major signaling pathways.

Mechanism
Drug mechanism of action

Developmental Projects
Summary field of developmental projects for the drug, including indication, developmental stage and status.
Example:
Cancer, myeloma - Phase II Clinical Trial - Active
Cancer, prostate - Phase III Clinical Trial - Ceased

Drug Description
Short introduction to drug

Compound Data
Compound type, Chemical name, CAS Number and molecular weight

Patent Data
Available patent information related to the drug is presented here.

Business & Markets
Collaborations and deals
Approvals and submissions
Analyst comments

Phase III Data
Available Phase III development data, developmental history and scientific data.

Phase II Data
Available Phase II development data, developmental history and scientific data.

Phase I Data
Available Phase I development data, developmental history and scientific data.

Preclinical Data
Available preclinical development data, developmental history and scientific data.

Licensing Information
Availability for licensing

Application Features Use 13 different parameters, available in drop-down menus, to find and sort among drugs